Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients: Staphylococcus aureus [2020]

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. ; Healthcare Infection Control Practices Advisory Committee (U.S.)
• Description:
  Recommendations for the Prevention and Control of Staphylococcus aureus in Neonatal Intensive Care Unit Patients provides new, evidence-based recommendations specific to the prevention and control of Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA), in neonatal intensive care unit (NICU) patients. This document is one section of the full Guideline for Infection Prevention and Control in Neonatal Intensive Care Unit Patients. This guideline will be published in a segmental manner as sections are completed. This section does not provide a comprehensive set of infection control recommendations for the prevention of S. aureus in NICU patients, but instead supplements other CDC guidelines. The term “S. aureus” includes both MSSA and MRSA. Core infection prevention and control recommendations for the prevention of S. aureus that apply across all healthcare settings are summarized in the Healthcare Infection Control Practices Advisory Committee (HICPAC) Core Practices document,1 and the original recommendations can be found in the respective Centers for Disease Control and Prevention (CDC) and HICPAC Guidelines.
  
  This document is intended for use by infection prevention staff, healthcare epidemiologists, healthcare administrators, nurses, neonatologists, other healthcare providers, and persons responsible for developing, implementing, and evaluating infection prevention and control programs for NICUs. The guideline can also be used as a resource for societies or organizations that wish to develop more detailed implementation guidance for the prevention of infection in NICU patients.
  
  The recommendations were based on a systematic review of the best available literature through August 2019. Subject matter experts supplemented the literature search results by recommending relevant references published since August 2019. In order to provide explicit links between the evidence and recommendations, an adapted GRADE approach was used to evaluate the strength and direction of the evidence and formulate recommendations. The Methods section of this guideline provides additional detail on the development of this document. Where evidence was insufficient to formulate evidence-based recommendations, interim guidance is available to inform the delivery of healthcare in NICUs: SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Staphylococcus aureus disease prevention (https://doi.org/10.1017/ice.2020.51).
  
  NICU-saureus-h.pdf
  
  
• Subjects:
  Cross Infection/prevention & Control Disease Outbreaks Infant, Newborn Infection Control Intensive Care Units, Neonatal Methicillin-Resistant Staphylococcus Aureus Personnel, Hospital Risk Factors Staphylococcal Infections/prevention & Control
• Document Type:
  Report
• Genre:
  Guideline
• Place as Subject:
  United States
• Pages in Document:
  29 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:2e60073a5188033d2e642f50c0b32197f857f6ade438f98d776a8dc4bde643594ad40c8c9cafe9ebc96ace0e63bd462e9d1fa2fbdc7d82ad0c6c4fcdc9f862ee
• Download URL:
  https://stacks.cdc.gov/view/cdc/93709/cdc_93709_DS1.pdf
• File Type:
  [PDF - 490.29 KB ]